Linsitinib
Product Specifications
CAS Number
867160-71-2
Target
IGF-1R
Related Pathways
Tyrosine Kinase/Adaptors
Purity
0.9992
Bioactivity
OSI-906 (Linsitinib (OSI-906) ) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGF-1R stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis.
Smiles
NC=1C=2N(C(=NC2C3=CC4=C(C=C3)C=CC(=N4)C5=CC=CC=C5)[C@H]6C[C@@](C)(O)C6)C=CN1
Molecular Formula
C26H23N5O
Molecular Weight
421.49
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/5812D72B-5C08-4AF6-93A8-4A29D0B09B72/T6017
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2063659-01 0.1 mL
FITC-Linked Polyclonal Antibody to Major Histocompatibility Complex Class II DR Alpha (MHCDRa)
Ask
View Details 
MBS2063659-02 0.2 mL
FITC-Linked Polyclonal Antibody to Major Histocompatibility Complex Class II DR Alpha (MHCDRa)
Ask
View Details MBS2063659-03 0.5 mL
FITC-Linked Polyclonal Antibody to Major Histocompatibility Complex Class II DR Alpha (MHCDRa)
Ask
View Details MBS2063659-04 1 mL
FITC-Linked Polyclonal Antibody to Major Histocompatibility Complex Class II DR Alpha (MHCDRa)
Ask
View Details